Search Results

1-20 of 27 results for subject:Reviews

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, whether further research recommended by a Health Protection Agency Rapid Review Panel report will be assessed by the panel at a later date; and whether a further report will be issued; how many applications have been reviewed by the Health Protection Agency's...

Asked by

Paul Burstow (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

11 January 2005

Reference

429 c515-6W; 206426;206428;206429;206430

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what the purpose is of the Food Standards Agency review led by Baroness Dean; what estimate he has made of the cost of the review; what account the review will take of the recent report of the National Audit Office and the...

Asked by

Lord Grayling (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

9 December 2004

Reference

201282; 428 c755W;428 c755-6W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what the evidential basis is for the statement by the Chief Medical Officer that there is strong evidence for the effectiveness of sex and relationships education.

Asked by

Andrew Turner (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

16 March 2004

For answer on

31 March 2004

Answered on

31 March 2004

Mr. Andrew Turner: To ask the Secretary of State for Health what the evidential basis is for the statement by the Chief Medical Officer that there is strong evidence for the effectiveness of sex and relationships education. [162493] Miss Melanie Johnson: Effective sex and relationships education (SRE) is essential if young people are to make responsible and well informed decisions about their lives. It should teach young people to understand human sexuality and to respect themselves and others. It enables young people to mature, to build up confidence and self-esteem and understand the reasons for delaying sexual activity. The position with regard to SRE in the Chief Medical Officer's Update is informed by high quality reviews of the international evidence. The most recent of these (Swann, C., Bowe, K., McCormick, G., and Kosmin, M. (2003) Evidence-Based briefing paper on teenage pregnancy and parenthood. Health Development Agency) considered the evidence from all high quality systematic and other reviews and meta-analyses published since 1996. They concluded that `good' evidence (for example, drawn from high quality reviews) exists for the effectiveness of `school-based sex education', particularly linked to contraceptive services (measured against knowledge, attitudes, delaying sexual activity and/or reducing pregnancy rates). In contrast, there was no good evidence for the effectiveness of abstinence based education (which focuses only on promoting sexual abstinence). The Health Development Agency was asked by the Department to undertake a review of the research evidence underpinning the teenage pregnancy strategy. They reviewed systematic reviews, meta-analyses and literature reviews of what works to prevent teenage pregnancy, which have been published since 1996. To be included reviews needed to meet strict quality criteria. This document was endorsed by an expert reference group and was subject to external peer review.

Date

31 March 2004

Reference

419 c1519-20W;419 c1521-2W; 162493

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will make a statement on the implementation of the Darzi Review recommendations on health care in County Durham. (Letter in Library Dep 04/268).

Asked by

Lord Beamish (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

27 January 2004

Reference

144868; 417 c326W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many staff at the Medicines and Health Care Products Regulatory Agency are employed to investigate breaches of the Medicines (Advertising) Regulations 1994; what the outcomes were of the review of advertising activities carried out by the Medicines and Health Care Products...

Asked by

Ian Gibson (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

18 December 2003

For answer on

6 January 2004

Answered on

6 January 2004

Dr. Gibson: To ask the Secretary of State for Health (1) how many staff at the Medicines and Health Care Products Regulatory Agency are employed to investigate breaches of the Medicines (Advertising) Regulations 1994; [145356] (2) what the outcomes were of the review of advertising activities carried out by the Medicines and Health Care Products Regulatory Agency earlier this year; which organisations and individuals were invited to contribute to this review; and how the report has been made publicly available; [145360] (3) how many of the complaints investigated by the Medicines and Health Care Products Regulatory Agency were found to be in breach of the Medicines (Advertising) Regulations in (a) 2001, (b) 2002 and (c) 2003; for each of these years, how many of the complaints that were upheld related to advertisements targeted at (i) health professionals and (ii) the public; over how long on average the advertisements had been running before being withdrawn; and what sanctions were employed; [145361] (4) what criteria are employed by the Medicines and Health Care Products Regulatory Agency in investigating complaints; and under what conditions pre-vetting of advertising material is carried out; [145362] (5) what provisions have been made by the Medicines and Health Care Products Regulatory Agency to take on additional staff to pre-vet advertising material when medicinal products are switched from prescription-only to over-the-counter status; [145357] (6) how many complaints were investigated in 2002-03 by the Medicines and Health Care Products Regulatory Agency in response to complaints from (a) health professionals, (b) pharmaceutical companies and (c) the public; [145358] (7) what self-regulatory controls are in place for medicine advertising and promotion; and when the Government last carried out a spot check to determine the effectiveness of the self-regulatory system; [145359] (8) what mechanisms exist for independent scrutiny of the Medicines and Health Care Products Regulatory Agency activities in relation to its role to monitor and enforce regulations on pharmaceutical company advertising and promotion. [145363] Miss Melanie Johnson: The control of medicines advertising is based on a long established system of self regulation underpinned by the statutory role of the Medicines and Healthcare products Regulatory Agency (MHRA). There are two main industry self regulatory bodies, the Prescription Medicines Code of Practice Authority (PMCPA) and Proprietary Association of Great Britain (PAGB). Both operate codes of practice for advertising of medicines and systems for investigating complaints against their codes. Advertising by PAGB member companies aimed at the public is pre-vetted by the PAGB prior to publication. There are also general controls on non-broadcast and broadcast advertising operated by the Advertising Standards Authority and the Office of Communications. Investigation of complaints and routine scrutiny of published advertising for medicines, concentrating on newly licensed products, provide an ongoing check on the effectiveness of the self-regulatory systems for medicines advertising. The MHRA meets regularly with the regulatory and self regulatory bodies to discuss current issues in medicines advertising. The MHRA investigates all complaints received about advertising against the requirements set out in the Medicines (Advertising) Regulations 1994. In 2002-03, 157 complaints about medicines advertising were investigated including 93 from health professionals, 16 from pharmaceutical companies and 48 from members of the public. The number of advertisements found to be in breach of the Regulations following investigation by the MHRA were 104 in 2001, 85 in 2002 and 108 in 2003. One quarter concerned advertisements aimed at health professionals and the remainder at the public. Information is not collected by the Agency on the length of time the advertisements had been running before being withdrawn. The primary sanction employed where advertising is considered to breach the Regulations is to require immediate withdrawal and amendment of the material. Additionally, in three cases in 2001, one in 2002 and five in 2003, all subsequent material was required to be submitted for pre-vetting. In 13 cases the company was required to issue a corrective statement, one in 2001, one in 2002 and 11 in 2003. One case was referred for enforcement action in 2001 and two in 2003. A public statement was also recently made on the outcome of three investigations into inducements to pharmacists. The MHRA has published criteria in Guidance Note 23--Advertising and Promotion of medicines in the UK (a copy of which is available in the Library) based on which it will consider requiring advertising material to be submitted for pre-vetting, including: (i) where a newly licensed product, subject to intensive monitoring, is placed on the market; (ii) where a product is reclassified, such as from prescription only medicine to pharmacy; or (iii) where previous advertising for a product has breached the Regulations. A recent internal MHRA review considered the procedures of the advertising unit in the regulation of advertising for medicines in the UK. It identified measures to increase and improve the targeting of pre- vetting, increase the use of corrective statements for misleading advertising, take rapid action on complaints prioritising those from health professionals and increase transparency by the publication of reports on completed actions on complaints. The outcome of the review was endorsed by the Medicines Commission and has been submitted for publication in a peer-reviewed journal. A copy of the report has also been placed in the Library. The MHRA employs four staff whose primary role is to regulate advertising for medicines, including investigation of breaches of the Medicines (Advertising) Regulations 1994. These staff draw on the wider resources of the MHRA to provide additional specialist advice on advertising casework as required. The MHRA anticipates that it will be able to manage any increase in the requirement for pre-vetting due to increases in reclassification from prescription only to over-the- counter status from within its existing resources. The National Audit Office and the Public Accounts Committee recently scrutinised the work of the MHRA, including its role in reviewing medicines advertising and promotion but did not make any recommendations in this area nor suggest any further review was necessary. The recent initiative to publish on the MHRA website the outcome of complaints investigations will increase the transparency of the MHRA's role in enforcing the regulations on advertising and promotion of medicines.

Date

6 January 2004

Reference

416 c310-2W; 145356;145360;145361;145362;145357;145358;145359;145363

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, when the findings of the investigation into the implementation of National Institute for Clinical Excellence guidance being undertaken will be published; which organisations have been formally consulted as part of the investigation into the implementation of National Institute for Clinical Excellence guidance;...

Asked by

Ian Gibson (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

5 January 2004

Reference

416 c200W;416 c201W; 144122;144123;144124;144125

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, pursuant to the Answer of 17th July 2003 at 409 c629W, on notifiable diseases, what the timetable is for the review of the infectious disease law.

Asked by

Mike Hancock (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

6 October 2003

Reference

128525; 410 c1333W

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, how many letters and submissions have been received by the DTI on the Higgs Report; and how many of these were in favour of its conclusions.

Asked by

Archie Norman (Conservative)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

7 May 2003

Reference

110398; 404 c705W;404 c700W

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, what plans she has to amend the Consumer Credit Act 1974; what the scope is of her review of the Consumer Credit Act 1974; when the Government intends to publish its review of the Consumer Credit Act 1974.

Asked by

Wayne David (Labour)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

22 January 2003

Reference

398 c365-6W;398 c365W; 92091;92092;92093

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, if she will make a statement on what conclusions she has reached as part of her Department's review of the Consumer Credit Act 1974 with respect to the questions of (a) how credit card annual percentage rates are calculated and...

Asked by

Norman Lamb (Liberal Democrat)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

16 January 2003

Reference

90030; 397 c792W;397 c791W

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, if she will make a statement on the recent Quinquennial Review of Citizens Advice Scotland. - (Quinquennial review in Library Dep 02/2196). (Printed on 04.11.2002 in Bound Volume 392 c146W)

Asked by

Ann McKechin (Labour)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

7 November 2002

Reference

392 c829W;392 (Not in Bound Volume); 79401

House

House of Commons

Dept of Trade and Industry

Asked by

Ann McKechin (Labour)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

4 November 2002

Reference

79401; 392 (Not in Daily Part);392 c146W

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, when the review of the Consumer Credit Act 1974 will be completed; what the terms of reference of that review are; and if she will make a statement.

Asked by

Andrew Love (Labour; Co-operative Party)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

19 September 2002

Reference

390 c188W; 73011

House

House of Commons

Dept of Trade and Industry

Statement on the recent quinquennial review of the National Association of Citizens Advice Bureaux. (Review in Library Dep 02/1672).

Asked by

Mark Hendrick (Labour; Co-operative Party)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

23 July 2002

Reference

389 c942-3W;389 c942W; 72972

House

House of Commons

Dept of Trade and Industry

Answered by

Melanie Johnson (Labour)

Answering body

Department of Trade and Industry

Type

Oral answers to questions

Date

11 July 2002

Reference

388 c1026

House

House of Commons

Dept of Trade and Industry

Answered by

Melanie Johnson (Labour)

Answering body

Department of Trade and Industry

Type

Oral answers to questions

Date

11 July 2002

Reference

388 c1026

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, If she will make a statement about the findings of the review of accounting standards.

Asked by

Desmond Swayne (Conservative)

Answering body

Department of Trade and Industry

Oral questions - Lead

Status

Answered

Date

11 July 2002

Reference

388 c1026; 66372

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, what plans she has to review the working of the Office of Fair Trading; and if she will make a statement. - (Holding answer 8 May 2002).

Asked by

Laurence Robertson (Conservative)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

16 May 2002

Reference

54661; 385 c779W

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, when the Office of Fair Trading will publish its response to the consultation on the review of the Newspaper Supply Code of Practice; how many responses the Office of Fair Trading received from (a) retailers, (b) wholesalers, (c) publishers and...

Asked by

Lord Cotter (Liberal Democrat)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

1 May 2002

Reference

384 c794W; 53007;52999

House

House of Commons

Dept of Trade and Industry

To ask the Secretary of State for Trade and Industry, pursuant to her Department's Answer of 24th January 2001 Official Report, 361 c632W, on the Insolvency Service, what progress the Insolvency Service has made in centralising its administrative functions in areas of (a) lower growth and (b) high unemployment.

Asked by

Nigel Waterson (Conservative)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

17 April 2002

Reference

42224; 383 c934W;383 c932W

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher